NDC 63323-415 – Neostigmine Methylsulfate
Neostigmine Methylsulfate 1 mg/mL · Injection, Solution · Intravenous
Product NDC63323-415
Product details
- Brand name
- Neostigmine Methylsulfate
- Generic name
- Neostigmine Methylsulfate
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- NDA · NDA203629
- Marketed since
- January 8, 2015
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cholinesterase Inhibitor
Active ingredients
- Neostigmine Methylsulfate 1 mg/mL
Uses, dosage, side effects and warnings for Neostigmine Methylsulfate →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 63323-415-10 | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-415-10) / 10 mL in 1 VIAL, MULTI-DOSE (63323-415-01) | Jan 8, 2015 |
| 63323-415-36 | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-415-36) / 10 mL in 1 VIAL, MULTI-DOSE | Jan 8, 2015 |
Other Neostigmine Methylsulfate products
- 43598-945 Neostigmine Methylsulfate 1 mg/mL · Injection, Solution · Dr.Reddys Laboratories Inc
- 63323-413 Neostigmine Methylsulfate .5 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 76045-214 Neostigmine Methylsulfate 1 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 76045-383 Neostigmine Methylsulfate 1 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 65219-811 Neostigmine Methylsulfate 1 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 70121-1479 Neostigmine Methylsulfate 1 mg/mL · Injection · Amneal Pharmaceuticals LLC
- 70121-1478 Neostigmine Methylsulfate .5 mg/mL · Injection · Amneal Pharmaceuticals LLC
- 0548-9601 Neostigmine Methylsulfate .5 mg/mL · Injection · Amphastar Pharmaceuticals, Inc.
- 0548-9602 Neostigmine Methylsulfate 1 mg/mL · Injection · Amphastar Pharmaceuticals, Inc.
- 71839-105 Neostigmine Methylsulfate .5 mg/mL · Injection · BE Pharmaceuticals Inc.
- 71839-106 Neostigmine Methylsulfate 1 mg/mL · Injection · BE Pharmaceuticals Inc.
- 31722-994 Neostigmine Methylsulfate .5 mg/mL · Injection · Camber Pharmaceuticals Inc.